{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:26:00Z","timestamp":1787430360145,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004870","name":"University of M\u00fcnster Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.molmed.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:34:16Z","timestamp":1780979656000},"page":"735-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Converging signalling disruptions: a threshold for Down syndrome hearts"],"prefix":"10.1016","volume":"32","author":[{"given":"Mariel","family":"Schwietzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Reinecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3334-2704","authenticated-orcid":false,"given":"Rinesh","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.05.002_bb0005","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41586-025-09593-9","article-title":"Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21","volume":"647","author":"Ranade","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.05.002_bb0010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00018-011-0884-2","article-title":"Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation","volume":"69","author":"Singh","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2026.05.002_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/32419","article-title":"Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum","volume":"392","author":"de la Pompa","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.05.002_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add6883","article-title":"Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome","volume":"16","author":"Lana-Elola","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2026.05.002_bb0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature04678","article-title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21","volume":"441","author":"Arron","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.05.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167811","article-title":"Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypes","volume":"134","author":"McKean","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41588-023-01399-7","article-title":"Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model","volume":"55","author":"Waugh","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2026.05.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107012","article-title":"Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling","volume":"26","author":"Chi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.molmed.2026.05.002_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ajhg.2012.08.017","article-title":"An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects","volume":"91","author":"Ackerman","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2026.05.002_bb0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ejhg.2010.224","article-title":"ALK2 mutation in a patient with Down\u2019s syndrome and a congenital heart defect","volume":"19","author":"Joziasse","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2026.05.002_bb0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygeno.2017.06.004","article-title":"Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases","volume":"109","author":"Pelleri","year":"2017","journal-title":"Genomics"},{"key":"10.1016\/j.molmed.2026.05.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002344","article-title":"Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects","volume":"7","author":"Grossman","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2026.05.002_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41419-021-03658-z","article-title":"The transcription factor Sox7 modulates endocardiac cushion formation contributed to atrioventricular septal defect through Wnt4\/Bmp2 signaling","volume":"12","author":"Hong","year":"2021","journal-title":"Cell Death Dis."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:00:17Z","timestamp":1787428817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491426001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1471491426001115"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.05.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Converging signalling disruptions: a threshold for Down syndrome hearts","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}